Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/8318
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartin, Pierre-Yvescat
dc.contributor.authorOhara, Mamikocat
dc.contributor.authorGinès i Gibert, Perecat
dc.contributor.authorXu, Ding Licat
dc.contributor.authorSt. John, Judycat
dc.contributor.authorNiederberger, Michelcat
dc.contributor.authorSchrier, Robert W.cat
dc.date.accessioned2009-05-15T08:50:14Z-
dc.date.available2009-05-15T08:50:14Z-
dc.date.issued1998cat
dc.identifier.issn0021-9738cat
dc.identifier.urihttp://hdl.handle.net/2445/8318-
dc.description.abstractNormalization of the increased vascular nitric oxide (NO) generation with low doses of NG-nitro-L-arginine methyl ester (L-NAME) corrects the hemodynamic abnormalities of cirrhotic rats with ascites. We have undertaken this study to investigate the effect of the normalization of vascular NO production, as estimated by aortic cyclic guanosine monophosphate (cGMP) concentration and endothelial nitric oxide synthase (eNOS) protein expression in the aorta and mesenteric artery, on sodium and water excretion. Rats with carbon tetrachloride-induced cirrhosis and ascites were investigated using balance studies. The cirrhotic rats were separated into two groups, one receiving 0.5 mg/kg per day of L-NAME (CIR-NAME) during 7 d, whereas the other group (CIR) was administrated the same volume of vehicle. Two other groups of rats were used as controls, one group treated with L-NAME and another group receiving the same volume of vehicle. Sodium and water excretion was measured on days 0 and 7. On day 8, blood samples were collected for electrolyte and hormone measurements, and aorta and mesenteric arteries were harvested for cGMP determination and nitric oxide synthase (NOS) immunoblotting. Aortic cGMP and eNOS protein expression in the aorta and mesenteric artery were increased in CIR as compared with CIR-NAME. Both cirrhotic groups had a similar decrease in sodium excretion on day 0 (0.7 versus 0.6 mmol per day, NS) and a positive sodium balance (+0.9 versus +1.2 mmol per day, NS). On day 7, CIR-NAME rats had an increase in sodium excretion as compared with the CIR rats (sodium excretion: 2.4 versus 0.7 mmol per day, P < 0.001) and a negative sodium balance (-0.5 versus +0.8 mmol per day, P < 0.001). The excretion of a water load was also increased after L-NAME administration (from 28+/-5% to 65+/-7, P < 0.05). Plasma renin activity, aldosterone and arginine vasopressin were also significantly decreased in the CIR-NAME, as compared with the CIR rats. The results thus indicate that normalization of aortic cGMP and eNOS protein expression in vascular tissue is associated with increased sodium and water excretion in cirrhotic rats with ascites.eng
dc.format.extent8 p.cat
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherAmerican Society for Clinical Investigationcat
dc.relation.isformatofReproducció del document publicat a http://dx.doi.org/10.1172/JCI626cat
dc.relation.ispartofJournal of Clinical Investigation, 1998, vol. 101, núm. 1, p. 235-242.cat
dc.relation.urihttp://dx.doi.org/10.1172/JCI626-
dc.rights(c) The American Society for Clinical Investigation, 1998cat
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationCirrosi hepàticacat
dc.subject.classificationAscitescat
dc.subject.classificationÒxid nítriccat
dc.subject.classificationVasodilatadorscat
dc.subject.classificationEdemacat
dc.subject.classificationFisiologia patològicacat
dc.subject.otherHepatic cirrhosiseng
dc.subject.otherAsciteseng
dc.subject.otherNitric oxideeng
dc.subject.otherVasodilationeng
dc.subject.otherEdemaeng
dc.subject.othereNOSeng
dc.titleNitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with asciteseng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec549717cat
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid9421486-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
549717.pdf177.62 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.